Maravai LifeSciences Forecast, price target & analysts
Maravai LifeSciences Target price 2026 - Analyst rating & recommendation
Maravai LifeSciences Classifications & Recommendation
Maravai LifeSciences Price Target
| Target Price | $7.14 |
| Price | $7.60 |
| Deviation |
6.05%
register free of charge
|
| Number of Estimates | 7 |
|
7 Analysts have issued a price target Maravai LifeSciences 2027 .
The average Maravai LifeSciences target price is $7.14.
This is
6.05%
register free of charge
$8.40
10.53%
register free of charge
$6.57
13.62%
register free of charge
|
|
| A rating was issued by 15 analysts: 10 Analysts recommend Maravai LifeSciences to buy, 5 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Maravai LifeSciences stock has an average upside potential 2027 of
6.05%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 185.74 | 215.85 |
| 28.34% | 16.21% | |
| EBITDA Margin | -67.96% | 15.98% |
| 158.74% | 123.51% | |
| Net Margin | -70.40% | -12.57% |
| 25.98% | 82.15% |
11 Analysts have issued a sales forecast Maravai LifeSciences 2026 . The average Maravai LifeSciences sales estimate is
This results in the following potential growth metrics:
10 Analysts have issued an Maravai LifeSciences EBITDA forecast 2026. The average Maravai LifeSciences EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
10 Maravai LifeSciences Analysts have issued a net profit forecast 2026. The average Maravai LifeSciences net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.91 | -0.10 |
| 13.33% | 89.01% | |
| P/E | negative | |
| EV/Sales | 9.64 |
10 Analysts have issued a Maravai LifeSciences forecast for earnings per share. The average Maravai LifeSciences EPS is
This results in the following potential growth metrics and future valuations:
Maravai LifeSciences...
Current Maravai LifeSciences Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| UBS |
Locked
➜
Locked
|
Locked | Sep 09 2026 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | Aug 07 2026 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | May 08 2026 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | Dec 15 2025 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Aug 12 2025 |
| Baird |
Locked
➜
Locked
|
Locked | May 13 2025 |
| Craig-Hallum |
Locked
➜
Locked
|
Locked | May 13 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
UBS:
Locked
➜
Locked
|
Sep 09 2026 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Aug 07 2026 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
May 08 2026 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Dec 15 2025 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Aug 12 2025 |
|
Locked
Baird:
Locked
➜
Locked
|
May 13 2025 |
|
Locked
Craig-Hallum:
Locked
➜
Locked
|
May 13 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
